Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing

Gamal Abou-Mohamed, Ravi Nagarajan, Tarek M. Ibrahim, Robert William Caldwell

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this study, we characterized the interactions of arbutamine, a novel catecholamine developed for use as a cardiac stress testing agent, with different adrenergic receptor subtypes in vitro. These effects were compared with those of isoproterenol. In the electrically stimulated left atria of rats, arbutamine increased contractile force. The pD2 values (-log of the dose that produces 50% of the maximal responses) for arbutamine and isoproterenol were 8.45 ± 0.15 and 8.55 ± 0.02, respectively. Metoprolol shifted the concentration-effect curves for both isoproterenol and arbutamine to the right with a pA2 value (-log of the dose of the antagonist that reduces the maximal responses of an agonist to 50%) of 7.22-7.5. Both arbutamine and isoproterenol increased the rate of spontaneously beating rat right atria with pot values of 9.0 ± 0.19 and 8.82 ± 0.18, respectively. The affinity constants (K(A)) of arbutamine and isoproterenol for cardiac beta1-adrenergic receptors, as determined by competition binding assays, were found to be 7.32 and 6.04, respectively. In guinea pig trachea, arbutamine and isoproterenol produced a concentration-dependent relaxation that was blocked by propranolol. Their pD2 values were 7.9 ± 0.1 and 8.2 ± 0.1, respectively. Arbutamine contracted isolated rat aortic rings with a maximal increase of 38.1 ± 6.7% that of 10 μM of norepinephrine. In rat white adipocytes, arbutamine, isoproterenol, and BRL-37344 stimulated glycerol release, with the order of potency being BRL-37344 > arbutamine > isoproterenol. In hamster brown adipocytes, the order was arbutamine > isoproterenol > BRL-37344. Moreover, arbutamine stimulated beta3-adrenergic receptors in guinea pig ileum. In conclusion, arbutamine is a novel catecholamine with similar potency and efficacy to that of isoproterenol. It stimulates cardiac beta1-, tracheal beta2-, and adiopocyte beta3-adrenergic receptors. Arbutamine does not stimulate alpha-adrenergic receptors at concentrations that were high enough to maximally activate the beta-adrenergic receptors.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalCardiovascular Drugs and Therapy
Volume10
Issue number1
DOIs
StatePublished - Jan 1 1996

Fingerprint

Adrenergic Agents
Pharmacology
Isoproterenol
Adrenergic Receptors
arbutamine
Heart Atria
Catecholamines
Guinea Pigs
White Adipocytes
Brown Adipocytes
Receptors, Adrenergic, alpha
Metoprolol
Receptors, Adrenergic, beta
Trachea
Ileum
Propranolol
Cricetinae
Glycerol
Norepinephrine

Keywords

  • Adrenergic receptors
  • Animal
  • Arbutamine
  • Dobutamine
  • Guinea pigs
  • Hamster
  • In vitro
  • Isoproterenol
  • Rats
  • Sympathomimetic amines

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. / Abou-Mohamed, Gamal; Nagarajan, Ravi; Ibrahim, Tarek M.; Caldwell, Robert William.

In: Cardiovascular Drugs and Therapy, Vol. 10, No. 1, 01.01.1996, p. 39-47.

Research output: Contribution to journalArticle

@article{f9733bc90bb04a1283b5faaf462cea25,
title = "Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing",
abstract = "In this study, we characterized the interactions of arbutamine, a novel catecholamine developed for use as a cardiac stress testing agent, with different adrenergic receptor subtypes in vitro. These effects were compared with those of isoproterenol. In the electrically stimulated left atria of rats, arbutamine increased contractile force. The pD2 values (-log of the dose that produces 50{\%} of the maximal responses) for arbutamine and isoproterenol were 8.45 ± 0.15 and 8.55 ± 0.02, respectively. Metoprolol shifted the concentration-effect curves for both isoproterenol and arbutamine to the right with a pA2 value (-log of the dose of the antagonist that reduces the maximal responses of an agonist to 50{\%}) of 7.22-7.5. Both arbutamine and isoproterenol increased the rate of spontaneously beating rat right atria with pot values of 9.0 ± 0.19 and 8.82 ± 0.18, respectively. The affinity constants (K(A)) of arbutamine and isoproterenol for cardiac beta1-adrenergic receptors, as determined by competition binding assays, were found to be 7.32 and 6.04, respectively. In guinea pig trachea, arbutamine and isoproterenol produced a concentration-dependent relaxation that was blocked by propranolol. Their pD2 values were 7.9 ± 0.1 and 8.2 ± 0.1, respectively. Arbutamine contracted isolated rat aortic rings with a maximal increase of 38.1 ± 6.7{\%} that of 10 μM of norepinephrine. In rat white adipocytes, arbutamine, isoproterenol, and BRL-37344 stimulated glycerol release, with the order of potency being BRL-37344 > arbutamine > isoproterenol. In hamster brown adipocytes, the order was arbutamine > isoproterenol > BRL-37344. Moreover, arbutamine stimulated beta3-adrenergic receptors in guinea pig ileum. In conclusion, arbutamine is a novel catecholamine with similar potency and efficacy to that of isoproterenol. It stimulates cardiac beta1-, tracheal beta2-, and adiopocyte beta3-adrenergic receptors. Arbutamine does not stimulate alpha-adrenergic receptors at concentrations that were high enough to maximally activate the beta-adrenergic receptors.",
keywords = "Adrenergic receptors, Animal, Arbutamine, Dobutamine, Guinea pigs, Hamster, In vitro, Isoproterenol, Rats, Sympathomimetic amines",
author = "Gamal Abou-Mohamed and Ravi Nagarajan and Ibrahim, {Tarek M.} and Caldwell, {Robert William}",
year = "1996",
month = "1",
day = "1",
doi = "10.1007/BF00051129",
language = "English (US)",
volume = "10",
pages = "39--47",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing

AU - Abou-Mohamed, Gamal

AU - Nagarajan, Ravi

AU - Ibrahim, Tarek M.

AU - Caldwell, Robert William

PY - 1996/1/1

Y1 - 1996/1/1

N2 - In this study, we characterized the interactions of arbutamine, a novel catecholamine developed for use as a cardiac stress testing agent, with different adrenergic receptor subtypes in vitro. These effects were compared with those of isoproterenol. In the electrically stimulated left atria of rats, arbutamine increased contractile force. The pD2 values (-log of the dose that produces 50% of the maximal responses) for arbutamine and isoproterenol were 8.45 ± 0.15 and 8.55 ± 0.02, respectively. Metoprolol shifted the concentration-effect curves for both isoproterenol and arbutamine to the right with a pA2 value (-log of the dose of the antagonist that reduces the maximal responses of an agonist to 50%) of 7.22-7.5. Both arbutamine and isoproterenol increased the rate of spontaneously beating rat right atria with pot values of 9.0 ± 0.19 and 8.82 ± 0.18, respectively. The affinity constants (K(A)) of arbutamine and isoproterenol for cardiac beta1-adrenergic receptors, as determined by competition binding assays, were found to be 7.32 and 6.04, respectively. In guinea pig trachea, arbutamine and isoproterenol produced a concentration-dependent relaxation that was blocked by propranolol. Their pD2 values were 7.9 ± 0.1 and 8.2 ± 0.1, respectively. Arbutamine contracted isolated rat aortic rings with a maximal increase of 38.1 ± 6.7% that of 10 μM of norepinephrine. In rat white adipocytes, arbutamine, isoproterenol, and BRL-37344 stimulated glycerol release, with the order of potency being BRL-37344 > arbutamine > isoproterenol. In hamster brown adipocytes, the order was arbutamine > isoproterenol > BRL-37344. Moreover, arbutamine stimulated beta3-adrenergic receptors in guinea pig ileum. In conclusion, arbutamine is a novel catecholamine with similar potency and efficacy to that of isoproterenol. It stimulates cardiac beta1-, tracheal beta2-, and adiopocyte beta3-adrenergic receptors. Arbutamine does not stimulate alpha-adrenergic receptors at concentrations that were high enough to maximally activate the beta-adrenergic receptors.

AB - In this study, we characterized the interactions of arbutamine, a novel catecholamine developed for use as a cardiac stress testing agent, with different adrenergic receptor subtypes in vitro. These effects were compared with those of isoproterenol. In the electrically stimulated left atria of rats, arbutamine increased contractile force. The pD2 values (-log of the dose that produces 50% of the maximal responses) for arbutamine and isoproterenol were 8.45 ± 0.15 and 8.55 ± 0.02, respectively. Metoprolol shifted the concentration-effect curves for both isoproterenol and arbutamine to the right with a pA2 value (-log of the dose of the antagonist that reduces the maximal responses of an agonist to 50%) of 7.22-7.5. Both arbutamine and isoproterenol increased the rate of spontaneously beating rat right atria with pot values of 9.0 ± 0.19 and 8.82 ± 0.18, respectively. The affinity constants (K(A)) of arbutamine and isoproterenol for cardiac beta1-adrenergic receptors, as determined by competition binding assays, were found to be 7.32 and 6.04, respectively. In guinea pig trachea, arbutamine and isoproterenol produced a concentration-dependent relaxation that was blocked by propranolol. Their pD2 values were 7.9 ± 0.1 and 8.2 ± 0.1, respectively. Arbutamine contracted isolated rat aortic rings with a maximal increase of 38.1 ± 6.7% that of 10 μM of norepinephrine. In rat white adipocytes, arbutamine, isoproterenol, and BRL-37344 stimulated glycerol release, with the order of potency being BRL-37344 > arbutamine > isoproterenol. In hamster brown adipocytes, the order was arbutamine > isoproterenol > BRL-37344. Moreover, arbutamine stimulated beta3-adrenergic receptors in guinea pig ileum. In conclusion, arbutamine is a novel catecholamine with similar potency and efficacy to that of isoproterenol. It stimulates cardiac beta1-, tracheal beta2-, and adiopocyte beta3-adrenergic receptors. Arbutamine does not stimulate alpha-adrenergic receptors at concentrations that were high enough to maximally activate the beta-adrenergic receptors.

KW - Adrenergic receptors

KW - Animal

KW - Arbutamine

KW - Dobutamine

KW - Guinea pigs

KW - Hamster

KW - In vitro

KW - Isoproterenol

KW - Rats

KW - Sympathomimetic amines

UR - http://www.scopus.com/inward/record.url?scp=0029932170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029932170&partnerID=8YFLogxK

U2 - 10.1007/BF00051129

DO - 10.1007/BF00051129

M3 - Article

VL - 10

SP - 39

EP - 47

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 1

ER -